fashion -WSS

fashion

author：fashion 2025-08-26 01:32:47 - browse：97

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Key House Republican on health care plans exit from Congress

focus

WSS

Robert F. Kennedy is pitching centrism on health, even on abortion

Robert F. Kennedy is pitching centrism on health, even on abortion

Medicare details structure of new drug price negotiation program

In Memoriam: Notable people who died in 2023

BioAge raises $170M for combination therapy with Zepbound

Anesthesiologist group: stop taking Ozempic before surgery

explore

fashion

focus

BioMarin wins approval for gene therapy to treat hemophilia A

KalVista pill reduced swelling 'attacks' caused by genetic disease

Supreme Court strikes down use of affirmative action

Medical records are filled with copy

How one medical school became remarkably diverse

What should King Charles tell the public about his cancer?

Walensky prepares to leave CDC — and Congress — behind

Private equity deals in Medicare Advantage declines

Guidelines to prevent youth baseball injuries need more muscle

Psychedelics group wrestles with new pharma identity

entertainment

Apple is now the first public company to be valued at $3 trillion

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What we’ve learned from the Aduhelm mess

Medical records are filled with copy

Moonlake's readout produced a cash windfall. Risks remain

Anesthesiologist group: stop taking Ozempic before surgery

Wikipedia

focus

focus

explore